The Lilabean Foundation, Inc.
The Lilabean Foundation, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma | Posterior Fossa Ependymal Tumor | Recruiting | Phase 2 | 2026-10-06 | NCT07226453 |